Company Analysis Unichem Laboratories Limited
1. Summary
Disadvantages
- Price (606.1 βΉ) is higher than fair price (600.72 βΉ)
- Dividends (0%) are below the sector average (9.06%).
- The stock's return over the last year (5.71%) is lower than the sector average (21.22%).
- Current debt level 7.81% has increased over 5 years from 6.35%.
- The company's current efficiency (ROE=-2.94%) is lower than the sector average (ROE=10.54%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
Unichem Laboratories Limited | Healthcare | Index | |
---|---|---|---|
7 days | 2.6% | 3.3% | -0.1% |
90 days | 8.9% | 14.8% | 3% |
1 year | 5.7% | 21.2% | 2.7% |
UNICHEMLAB vs Sector: Unichem Laboratories Limited has significantly underperformed the "Healthcare" sector by -15.51% over the past year.
UNICHEMLAB vs Market: Unichem Laboratories Limited has outperformed the market by 3.03% over the past year.
Stable price: UNICHEMLAB is not significantly more volatile than the rest of the market on "National Stock Exchange Of India" over the last 3 months, with typical variations of +/- 5% per week.
Long period: UNICHEMLAB with weekly volatility of 0.1098% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (606.1 βΉ) is higher than the fair price (600.72 βΉ).
Price is higher than fair: The current price (606.1 βΉ) is 0.9% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (57.6) is lower than that of the sector as a whole (59.52).
P/E vs Market: The company's P/E (57.6) is lower than that of the market as a whole (66.04).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.48) is lower than that of the sector as a whole (6.59).
P/BV vs Market: The company's P/BV (1.48) is lower than that of the market as a whole (6.6).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.12) is lower than that of the sector as a whole (9.3).
P/S vs Market: The company's P/S indicator (2.12) is lower than that of the market as a whole (18.95).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (48.53) is lower than that of the sector as a whole (141.59).
EV/Ebitda vs Market: The company's EV/Ebitda (48.53) is higher than that of the market as a whole (24.96).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 3.42% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (3.42%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-3.49%).
5.4. ROE
ROE vs Sector: The company's ROE (-2.94%) is lower than that of the sector as a whole (10.54%).
ROE vs Market: The company's ROE (-2.94%) is lower than that of the market as a whole (3.54%).
5.5. ROA
ROA vs Sector: The company's ROA (-2.22%) is lower than that of the sector as a whole (7.51%).
ROA vs Market: The company's ROA (-2.22%) is lower than that of the market as a whole (7.89%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-7.35%) is lower than that of the sector as a whole (16.06%).
ROIC vs Market: The company's ROIC (-7.35%) is lower than that of the market as a whole (15.45%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '9.06%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (-0.1056%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription